Celldex Therapeutics, Inc.
- Stock
- Ticker CLDX
- ISIN US15117B2025
- Nasdaq
Performance, volatility and drawdowns of Celldex Therapeutics, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $3,906. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −97.8% in 03/2020, measured from the peak in 11/2016. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 1.2 | 0.7 | 0.7 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Operating income | -56 | -63 | -64 | -74 | -87 | -84 | -81 | -82 |
| EBITDA | -55 | -62 | -63 | -73 | -86 | -84 | -80 | -81 |
| Net income | -47 | -54 | -57 | -67 | -81 | -79 | -74 | -76 |
| Earnings per share | -0.71 | -0.81 | -0.85 | -1.01 | -1.23 | -1.18 | -0.94 | -0.96 |
| Balance sheet | ||||||||
| Total assets | 792 | 739 | 692 | 648 | 583 | 511 | 782 | 722 |
| Liabilities | 45 | 36 | 37 | 50 | 56 | 55 | 68 | 72 |
| Equity | 747 | 703 | 655 | 598 | 527 | 456 | 715 | 649 |
| Cash | 28 | 17 | 23 | 36 | 29 | 36 | 47 | 27 |
| Cash flow | ||||||||
| Operating cash flow | -32 | -54 | -44 | -49 | -64 | -66 | -57 | -65 |
| Capital expenditure | -0.8 | -0.3 | -0.7 | -0.4 | -1.3 | -1.6 | -3.2 | -1.7 |
| Free cash flow | -33 | -55 | -45 | -49 | -65 | -67 | -61 | -67 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +685.7%, weakest 2018 at −93.0%. 4 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.96 |
| 6 Aug 2026 | −$0.94 |
| 7 May 2026 | −$1.18 |
| 25 Feb 2026 | −$1.23 |
| 10 Nov 2025 | −$1.01 |
| 7 Aug 2025 | −$0.85 |
| 8 May 2025 | −$0.81 |
| 27 Feb 2025 | −$0.71 |
| 6 Nov 2024 | −$0.64 |
| 8 Aug 2024 | −$0.54 |
| 6 May 2024 | −$0.56 |
| 26 Feb 2024 | −$0.84 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.0bn
- Market cap in trading currency
- $2.15bn
- Enterprise value
- $1.50bn
- P/E
- –
- P/S
- 13,631.05
- P/B
- 3.32
- EV/Sales
- 9,515.10
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -12.1%
Results (last four quarters)
- Revenue
- $158,000
- Gross profit
- –
- EBITDA
- −$331m
- Net income
- −$309m
- Earnings per share
- −$4.31
- Revenue per share
- $0.00
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -211,684.8%
- Net margin
- -195,608.9%
- Return on equity
- -49.5%
- Return on assets
- -42.8%
Balance sheet and cash flow
- Cash
- $650m
- Cash per share
- $8.28
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 10.97
- Book value per share
- $8.27
- Operating cash flow
- −$252m
- Free cash flow
- −$260m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 78.5m
- Volume
- 1.69m
- Avg. volume 3 months
- 1.36m
- Relative volume
- 1.3
Price and technicals
- Price
- $27.42
- 1 day
- −1.9%
- 52-week high
- $44.87
- 52-week low
- $22.58
- Distance to 52-week high
- −38.9%
- Distance to 52-week low
- +21.4%
- Distance to 50-day line
- −11.3%
- Distance to 200-day line
- −16.7%
- RSI (14)
- 39
- Volatility 1M
- 45.2%
Performance
- 1 week
- −4.9%
- 1 month
- −5.4%
- 3 months
- −32.4%
- 6 months
- −10.8%
- YTD
- +1.0%
- 1 year
- +10.0%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CLDX performed since 11/2016?
$10,000 grew to $3,906 by 20 Nov 2026, which is −9.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CLDX?
Volatility was 145.5% per year, measured on monthly returns. The largest decline from a peak was −97.8%, with the low in 03/2020.
How does CLDX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CLDX returned −9.0% at 145.5%. The correlation of monthly returns was 0.23; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.